The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.
Bharat Biotech CMD Dr Krishna Ella said final phase of clinical trial is over & they hope to get licence soon. NIV Director Dr Priya Abraham said vaccines may be available by Sept.
Covaxin had earlier this month received a certificate of Good Manufacturing Practice compliance from Hungary, which paved a way for another significant milestone for Bharat Biotech.
The Central Drugs Standard Control Organisation on 29 July had recommended granting permission to the study that will be conducted by the Christian Medical College in Vellore.
In a written reply to Rajya Sabha Friday, Health Minister Mansukh Mandaviya said that three Public Sector Enterprises will also be supported to manufacture Covaxin.
The statement from Hyderabad-based Covid vaccine manufacturer comes after reports surfaced claiming that Covaxin's test batches from the Bengaluru plant were not satisfactory.
The approval came from the National Institute of Pharmacy and Nutrition Hungary and it marks the first compliance certificate received by Bharat Biotech from European regulators.
Indian judiciary has a corrosive imbalance between the bar and the bench. Those who supervise the district judiciary do so without the lived experience that is essential for meaningful reform.
November exports to the US saw 10% growth from the previous month. Overall, in the first 8 months this fiscal, the merchandise exports to the US touched has touched $59bn.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS